Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 09 Sept 2019 for Lite Strategy, Inc., €24k.
Filing timeline
BuySaleChristine Anna White
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +40.3%Entry US$38.20 · Close at T+365 US$53.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christine Anna White: trading record in brief
Christine Anna White has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Arena Pharmaceuticals Inc and Lite Strategy, Inc. We count 2 filings; the first trade dates from 13 June 2016 and the latest from 6 September 2019.
The open-market side counts 1 purchase for €24k alongside 1 sale for €33k. Sales outweigh purchases by €9,358. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2019, the count stands at 1 purchase and no sales.
The latest filing, published on 9 September 2019, reports an open-market purchase of €24k in Lite Strategy, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christine Anna White
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,000 shares@ US$1.74100.0% of flowCommon StockSEC:0001209191-19-048913:0
Canonical exit: 5 Dec 2019 (T+90)
18,728 shares@ US$1.99Common StockSEC:0001371859-16-000002:0
2 of 2 declarations
